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Abstract
Introduction:  Head  and  neck  tumors  can  be  easily  recognized  through  clinical  evaluation.  How-
ever, they  are  often  diagnosed  at  advanced  stages.
Objective:  To  evaluate  the  delay  from  the  patient’s  initial  symptoms  to  the  deﬁnitive  treat-
ment.
Methods:  Retrospective  study  of  patients  enrolled  in  2011  and  2012.  A  questionnaire  was  ﬁlled
in about  socioeconomic  aspects,  patient  history,  tumor  data,  professionals  who  evaluated  the
patients, and  the  respective  time  delays.
Results:  The  following  time  delay  medians  were  observed:  ten  months  between  symptom  onset
and the  ﬁrst  consultation;  four  weeks  between  the  latter  and  the  ﬁrst  consultation  with  a
specialist; four  weeks  between  the  specialist  consultation  and  diagnosis  attainment;  and  12
weeks between  diagnosis  and  the  start  of  treatment.
Conclusions:  Most  head  and  neck  tumors  are  diagnosed  at  advanced  stages,  due  to  patient  and
health care  factors.
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Impacto  da  demora  no  diagnóstico  e  tratamento  no  câncer  de  cabec¸a e  pescoc¸o
Resumo
Introduc¸ão:  Apesar  de  poderem  ser  facilmente  reconhecidos  ao  exame  clínico,  os  tumores  de
cabec¸a e  pescoc¸o  são,  muitas  vezes,  diagnosticados  em  estadiamento  avanc¸ado.
Objetivo:  Avaliar  a  demora  entre  o  surgimento  dos  sintomas  iniciais  do  paciente  e  seu  encam-
inhamento  para  o  tratamento  deﬁnitivo.
Método:  Trata-se  de  um  estudo  retrospectivo  de  pacientes  arrolados  em  2011  e  2012.  Foi
preenchido  questionário  sobre  fatores  sócio-econômicos,  antecedentes,  dados  do  tumor,  proﬁs-
sionais que  avaliaram  os  pacientes  e  respectivos  períodos  de  demora.
Resultados:  Foram  observadas  as  seguintes  medianas  de  tempo  de  demora:  10  meses  entre  o
início dos  sintomas  e  o  primeiro  atendimento;  4  semanas  entre  este  e  a  primeira  consulta  com
o especialista;  4  semanas  entre  esta  e  o  estabelecimento  do  diagnóstico;  e  12  semanas  entre
este e  o  início  do  tratamento.
Conclusões:  A  maior  parte  dos  cânceres  de  cabec¸a  e  pescoc¸o  é  diagnosticada  em  estádios
avanc¸ados, por  fatores  relacionados  aos  pacientes  e  à  atenc¸ão  à  saúde.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publi-
cado por  Elsevier  Editora  Ltda.  Este  é  um  artigo  Open  Access  sob  a  licença  CC  BY
(https://creativecommons.org/licenses/by/4.0/deed.pt).
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Head  and  neck  tumors  are  relatively  easy  to  visualize  or
palpate  at  the  clinical  examination.  Nevertheless,  many
patients  are  diagnosed  at  advanced  stages  of  the  disease,
perhaps  due  to  the  lack  of  early  alarming  symptoms.  This
results  in  a  lack  of  motivation  to  seek  medical  attention.1,2
Head  and  neck  cancers  are  often  at  an  already  advanced
stage  when  diagnosed.  The  greater  the  delay  in  diagnosis
and  the  onset  of  treatment,  the  more  advanced  the  stage,
the  more  aggressive  the  necessary  therapy,  and  the  worse
the  prognosis.  This  makes  a  fast  and  efﬁcient  diagnosis  a
challenge.2 Understanding  the  reasons  responsible  for  late
diagnosis  of  head  and  neck  cancer  could  help  to  design  inter-
ventions  aimed  at  reducing  the  frequency  of  unfavorable
outcomes.
If  the  time  period  between  the  initial  consultation  and
treatment  is  prolonged,  patients  may  experience  tumor  and
clinical  stage  progression,  which  affects  the  therapeutic
schedule  with  possible  negative  inﬂuence  on  prognosis.  This
is  a  relevant  clinical  problem,  as  comorbidity  control  prior
to  surgical  treatment  may  require  a  long  period.3
Lesion  location  and  the  different  forms  of  tumor  presen-
tation  and  symptoms  may  contribute  to  the  delay.  Silent
tumors,  those  with  difﬁcult  access,  or  those  that  take
longer  to  manifest  obvious  symptoms  hinder  the  patient’s
perception,  delaying  the  entire  diagnostic  process.4,5 There-
fore,  very  often,  depending  on  the  symptoms,  it  takes  the
patient  longer  to  seek  medical  care.6 Studies  have  suggested
increasing  the  awareness  of  individuals  considered  at  risk,
such  as  smokers  and  drinkers,  to  seek  medical  help  after
the  initial  symptoms,  which  favors  prognosis.7 However,  such
delay  may  also  be  due  to  factors  related  to  professional  care
and  health  care,  with  a  time  ranging  in  literature  from  four
days  to  3.5  months.5
The  aim  of  this  study  is  to  assess  the  delay  from  symptom
onset  to  the  start  of  deﬁnitive  treatment,  and  to  identify
1
2ny  association  between  the  delay  and  the  patient’s  socio-
conomic  status  and  tumor  staging.
ethods
his  study  was  approved  by  the  ethics  committee  of  the
nstitution  where  it  was  carried  out,  under  No.  730.552.
his  is  a  retrospective  study  of  new  cases  of  squamous  cell
arcinoma  of  the  upper  aerodigestive  tract,  diagnosed  at
he  Outpatient  Clinic  of  Head  and  Neck  Surgery  of  the  insti-
ution,  from  January  2011  to  August  2012.  Tumors  of  the
alivary  glands  and  thyroid  were  excluded  from  this  study,
s  they  have  different  clinical  presentation  and  biological
ehaviors  from  carcinoma  of  the  upper  aerodigestive  tract.
Patients  completed  a  questionnaire  focused  on  epidemi-
logical,  disease,  and  treatment  factors.  Illiterate  patients
ere  aided  by  an  accompanying  family  member  and  one
f  the  authors  was  always  available  to  resolve  any  doubts.
he  following  data  were  collected:  identiﬁcation  (name
nd  registration  number  at  the  institution),  age  (in  years),
ender,  ethnicity,  educational  level  (from  none  to  col-
ege/university),  smoking  and  alcohol  consumption  (both
easured  semi-quantitatively)  and  primary  tumor  location.
umors  were  staged  according  to  the  sixth  edition  of  the  TNM
lassiﬁcation  of  the  American  Joint  Committee  on  Cancer
AJCC).  The  professionals  who  treated  the  patient  previ-
usly,  as  well  as  the  main  modality  of  cancer  treatment
he  patient  underwent  (surgery,  radiotherapy,  or  palliative
hemotherapy)  were  also  assessed.
The  following  durations  were  measured:.  Interval  between  the  reported  symptom  onset  and  seek-
ing  medical  care  (in  months);
.  Interval  between  the  ﬁrst  medical  or  dental  appointment
and  the  ﬁrst  consultation  with  the  specialist  (in  weeks);
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Table  1  Epidemiological  data  of  the  assessed  patients
(n =  80).
n  %
Gender
Male  75  93.75
Female  5  6.25
Ethnicity
White 63  78.75
Non-white  17  21.5
Smoking
Regular  smoker  79  98.75
Non-smoker  1  1.25
Alcohol  consumption
Regular  user  42  52.5
Non-user  38  47.5
Level of  schooling
<Elementary  school 42  52.5
Elementary  school  32  40
<High school  3  3.75
High school  3  3.75
Primary  sites
Lips  2  2.5
Oral cavity  33  41.25
Oropharynx  8  10
Hypopharynx  5  6.25
Larynx 25  31.25
Paranasal  sinuses  3  3.75
Primary  occult  4  5
Clinical  staging
EC I  5  6.25
EC II  8  10
EC III  23  28.75
EC IV  44  55
Main modality  of  referral
Surgery  23  28.75
Radiotherapy  52  65
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a  health  professional  and  the  ﬁrst  consultation  with  a  spe-Chemotherapy  (palliative)  5  6.25
.  Interval  between  the  ﬁrst  consultation  with  the  specialist
and  the  attainment  of  the  diagnosis  --  anatomopatholog-
ical  results  (in  weeks);.  Interval  between  diagnosis  attainment  and  start  of  the
treatment  (in  weeks). c
c
c
Table  2  Median  and  range  of  the  intervals  studied  (n  =  80).
Interval  
Symptom  onset  --  seeking  health  care  service  (months)  
First consultation  with  a  general  practitioner  --  ﬁrst  consultation  w
First consultation  with  a  specialist  --  establishing  the  diagnosis  (we
Diagnosis --  start  of  the  treatment  (weeks)  Felippu  AWD  et  al.
esults
f  the  80  patients  identiﬁed,  75  were  males  (93.75%),  and
3  were  white  (78.75%).  Age  ranged  from  45  to  73  years,
ith  a  median  of  63  years.  Most  of  them  regularly  consumed
obacco  products  (98.75%)  and  alcohol  (52.5%).  As  for  edu-
ational  level,  most  had  not  ﬁnished  elementary  school:  42
52.5%).  Among  the  tumor  sites,  the  most  frequent  ones
ere  oral  cavity,  33  (41.84%),  and  larynx,  25  (31.25%).  The
istribution  of  the  initial  clinical  stages  showed  a  predomi-
ance  of  EC  III,  23  (28.75%)  and  EC  IV,  44  (55%)  (Table  1).
All  80  patients  underwent  a  consultation  with  a
on-specialist  in  head  and  neck  surgery:  45  with  an  otorhi-
olaryngologist,  38  with  a  generalist,  12  with  a dentist,  and
ight  with  other  specialties,  i.e., three  patients  went  to
hree  different  professionals  before  having  a  consultation
ith  the  expert,  and  14  had  a  consultation  with  two  different
rofessionals  beforehand.
The  median  time  between  symptom  onset  and  seeking
edical  care  was  ten  months;  four  months  between  the
rst  general  consultation  motivated  by  the  tumor  and  the
rst  visit  to  the  specialist;  between  the  latter  and  diag-
osis  attainment,  four  months;  and  between  the  diagnosis
ttainment  and  start  of  the  treatment,  12  months  (with  no
ifference  between  the  main  treatment  modalities  to  which
atients  were  referred  to)  (Table  2).
iscussion
here  is  a  consensus  that  the  prognosis  of  head  and  neck
ancer  at  advanced  stages  (EC  III  and  IV)  is  worse  than  that
bserved  in  tumors  diagnosed  in  the  early  stages.  Any  delay
n  diagnosis  and  treatment  can  lead  to  a  progression  to  more
dvanced  stages,  and  thus  a  decrease  in  cure  rates  and  treat-
ent  effectiveness.3 If  the  advanced  disease  is  the  result  of
he  delay  in  case  presentation  or  management,  it  can  be
oncluded  that  the  reduction  of  such  interval  would  lead  to
reatment  at  an  earlier  stage,  increasing  survival  rates  and
educing  morbidity.4
The  delay  in  diagnosis  refers  to  the  total  period  of  time
etween  symptom  onset  and  when  the  diagnosis  is  estab-
ished.  From  then  until  the  start  of  the  treatment,  the  delay
ccurs  in  treatment  planning  and  performance.  One  can  also
ivide  the  delay  into  two  phases:  the  period  from  symp-
om  onset  to  the  seeking  of  medical  care  (patient  delay)
nd  the  excessive  time  between  the  ﬁrst  consultation  withialist  (health  system  delay).8 This  delay  by  the  professional
ould  also  be  deﬁned  as  the  time  between  the  ﬁrst  medi-
al  consultation  (usually  with  a  non-specialist)  and  the  date
Median  Range
10  8--48
ith  a  specialist  (weeks)  4  2--180
eks)  4  2--8
12  2--16
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of  the  histopathological  diagnosis.  While  professional  delay
can  be  measured  relatively  accurately,  patient  delay  tends
to  show  assessment  error,  as  it  depends  on  its  degree  and
perception.9
It  is  believed  that  a  longer  period  from  symptom  onset
to  diagnosis  conﬁrmation  would  explain  the  fact  that  the
disease  is  diagnosed  at  advanced  stages.8 Patient  delay
in  seeking  medical  care  can  be  due  to  factors  related
to  the  tumor,  such  as  the  primary  tumor  site  and  its
characteristics,  sometimes  oligosymptomatic.  Additionally,
sociodemographic  variables,  such  as  socioeconomic  status,
can  inﬂuence  delay.  Psychological  factors  must  also  be
considered.6
In  the  present  series,  treated  at  a  public  outpatient
clinic,  the  median  time  of  symptom  onset  to  medical  consul-
tation  was  ten  months.  This  delay  can  be,  in  part,  attributed
to  speciﬁc  patient  factors.1,2 The  population’s  difﬁculty  in
accessing  a  specialist  seems  to  be  due  in  part  to  their  low
socioeconomic  status.  Sometimes  they  lack  funds  even  for
the  use  of  public  transport.  Patient  delay,  as  mentioned
before,  is  difﬁcult  to  measure  accurately  because  it  is  based
on  perception,  which  is  highly  subjective  and  can  be  inﬂu-
enced  by  many  social  and  cultural  factors.9 Additionally,
when  considering  the  entire  case  management,  patients
should  also  be  carefully  instructed  about  the  return  visits
and  follow-up.1
In  the  present  study,  the  median  time  for  a  patient  to  be
referred  from  primary  care  to  a  specialist  (head  and  neck
surgeon)  was  four  weeks.  One  of  the  relatively  quick  factors
was  the  fact  that  the  initial  evaluation  was  conducted  by
an  otorhinolaryngologist,  who  recognized  the  situation  and
referred  the  patient  to  the  cancer  specialist.
However,  it  took  some  patients  a  long  time  to  have  a
consultation  with  the  head  and  neck  surgeon,  and  in  this
case,  the  authors  mainly  recognize  the  lack  of  self-care  on
the  part  of  most  of  these  patients,  who  neglected  their
condition.  However,  other  patients  experienced  a  relative
delay  because  of  the  professionals  involved,  as  the  patients
had  more  than  one  consultation  before  the  appointment
with  the  specialist.  Indeed,  some  general  health  care  pro-
fessionals  failed  to  recognize  certain  signs  and  symptoms  as
suggestive  of  malignancy.
There  are  many  problems  involving  delay  in  diagnosis,
especially  in  the  public  health  care  system;  there,  a  prompt
initiation  of  an  indicated  treatment,  including  surgery,  is
not  always  possible.  It  is  not  only  the  intellectual  and  social
status  of  the  patient  that  impacts  the  difﬁculty  in  treating
head  and  neck  cancer,  but  also  the  many  shortcomings  of
the  public  health  care  service,  including  referral,  scheduling
tests  and  treatment.
Studies  have  documented  lower  survival  rates  in  popu-
lations  with  a  poorer  socioeconomic  status.10 This  reﬂects
the  occurrence  of  more  advanced  tumors  in  this  group
due,  in  part,  to  the  lack  of  education  (with  limited  use  of
preventive  behaviors  for  health),  delay  in  seeking  medical
care,  and  the  reality  of  insufﬁcient  medical  care.9 Even  in
cases  of  tumors  whose  location  would  facilitate  the  diag-
nosis  --  such  as  oral  cancer  --  there  is  a  tendency  to  delay,
attributed  to  patient  factors,  as  well  as  health  professional
factors--physicians  and  dentists.11 Much  time  is  also  lost
1 cancer  143
aiting  for  the  scheduling  of  more  sophisticated  imaging
ethods,  often  important  for  tumor  staging,  a  crucial  step
o  deﬁne  the  therapeutic  strategy  to  be  used.
After  the  anatomopathological  diagnosis  is  established,
he  median  time  to  the  start  of  treatment  was  12  weeks.
his  delay  occurred  irrespective  of  the  main  therapeutic
odality  for  which  the  patient  was  referred  (surgery,  radi-
tion  therapy,  or  palliative  chemotherapy),  as  it  represents
he  current  global  reality  of  the  public  health  care  system
atient  in  Brazil.  This  time  includes  the  scheduling  of  the
rst  consultation  and  treatment  planning.
onclusion
ost  head  and  neck  malignant  tumors  are  diagnosed  at
dvanced  stages.  Delay  occurred  in  all  periods,  both  for
iagnosis  and  treatment,  due  to  both  patient  as  well  as
ealth  care  factors.
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